Extensive research in countries with high sociodemographic indices (SDIs) to date has
shown that coronavirus disease 2019 (COVID-19) may be directly associated with more …

VHH, ie, VH domains of camelid single-chain antibodies, are very promising therapeutic
agents due to their significant physicochemical advantages compared to classical …

SARS-CoV-2 variants with adaptive mutations have continued to emerge, causing fresh
waves of infection even amongst vaccinated population. The development of broad …

Global health and economy are deeply influenced by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and its newly emerging variants. Nanobodies with nanometer …

The COVID-19 pandemic has driven biotechnological developments to provide new and
more effective tools for prophylaxis, diagnosis, and therapy. Historically, monoclonal …

Background The emergence of the coronavirus disease 2019 (COVID-19) pandemic and the
new severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants of concern …

Influenza A virus poses a constant challenge to human health. The highly conserved
influenza matrix-2 (M2) protein is an attractive target for the development of a universal …

In this work, we developed llama-derived nanobodies (Nbs) directed to the receptor binding
domain (RBD) and other domains of the Spike (S) protein of SARS-CoV-2. Nanobodies …

Introduction The human respiratory syncytial virus (hRSV) is the leading cause of respiratory
infections in children, older adults, and patients with comorbidities. Since the hRSV …

The COVID-19 pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) heavily burdened the entire world. Despite a prompt generation of vaccines …